OxLDL-derived lysophosphatidic acid promotes the progression of aortic valve stenosis through a LPAR1-RhoA–NF-κB pathway
Mohamed Jalloul Nsaibia(Institut Universitaire de Cardiologie et de Pneumologie de Québec), Patrick Mathieu(Institut universitaire de cardiologie et de pneumologie de Québec)
Cited by 94
Related Papers
A Mendelian randomization study of IL6 signaling in cardiovascular diseases, immune-related disorders and longevity
|npj Genomic Medicine|2019|174
Innate and Adaptive Immunity in Calcific Aortic Valve Disease
|Journal of Immunology Research|2015|115
Increased Biglycan in Aortic Valve Stenosis Leads to the Overexpression of Phospholipid Transfer Protein via Toll-Like Receptor 2
|American Journal Of Pathology|2010|71
High Expression of the Pi-Transporter SLC20A1/Pit1 in Calcific Aortic Valve Disease Promotes Mineralization through Regulation of Akt-1
|PLoS ONE|2013|59
DNA methylation of a PLPP3 MIR transposon-based enhancer promotes an osteogenic programme in calcific aortic valve disease
|Cardiovascular Research|2018|40